Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group
Keywords:
Diffuse large B-cell lymphoma
Lenalidomide
Salvage
R-ESHAP
Rituximab
Editorial note:
Copyright © 1999-2024 John Wiley & Sons, Inc or related companies. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Citation:
Canales-Albendea, M. A. (Miguel Ángel); Martin, A. (Alejandro); Redondo, A. M. (Alba M.); et al. "Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: a phase 1b study from GELTAMO group". British Journal of Haematology. 173 (2), 2016, 245 - 252
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.